Suppr超能文献

非布芬在几种实验动物中的处置与代谢。

Disposition and metabolism of fenbufen in several laboratory animals.

作者信息

Chiccarelli F S, Eisner H J, Van Lear G E

出版信息

Arzneimittelforschung. 1980;30(4A):707-15.

PMID:6776965
Abstract

Absorption, distribution, metabolism and excretion studies with gamma-oxo-(1,1'-biphenyl)-4-butanoic acid (fenbufen) have been conducted in several laboratory animal species. Single oral doses of 14C-fenbufen were administered to rats, guinea pigs, rabbits and dogs (10, 40 and 100 mg/kg) and to mice and monkeys (40 and 100 mg/kg); rats, rabbits and dogs received an i.v. dose of 10 mg/kg. Multiple oral doses of 40 mg/kg of non-radiolabelled fenbufen were studied in the rat and dog. Plasma concentrations of fenbufen and its metabolites were dose dependent with areas under the curve showing general linearity both within and among species over the range studied (10--100 mg/kg). Radioactivity was present in all tissues examined following a dose of 10 mg/kg 14C-fenbufen orally to rats and guinea pigs. Except for gastrointestinal tract, liver and kidney these tissue levels were usually lower than the corresponding plasma level through 24 h post dose. The major drug-related material in plasma of the rat, guinea pig and dog was (1,1'-biphenyl)-4-acetic acid; in the monkey it was gamma-hydroxy(1,1'-biphenyl)-4-butanoic acid. These two compounds together with unchanged fenbufen were present in the plasma of all the animals studied. In addition 4'-hydroxy(1,1'-biphenyl)-4-acetic acid was found in rat plasma and beta, gamma-dihydroxyl(1,1'-biphenyl)-4-butanoic acid in dog plasma. The plasma profiles of fenbufen and metabolites did not change during multiple, daily oral doses of 40 mg/kg in either the rat (up to 10 days) or the dog through 18 months. In varying proportions, a total of 11 metabolites (including those listed above) together with fenbufen itself were isolated and characterized from the urine of mice, rats, guinea pigs, dogs and/or monkeys dosed with fenbufen. Within each of the species studied, excretion patterns of drug-related materials in the urine and feces following an i.v. dose were similar to those following the oral doses. In general urine was the major excretory pathway.

摘要

已在几种实验动物中进行了γ-氧代-(1,1'-联苯)-4-丁酸(芬布芬)的吸收、分布、代谢和排泄研究。给大鼠、豚鼠、兔和狗(10、40和100mg/kg)以及小鼠和猴(40和100mg/kg)口服单剂量的14C-芬布芬;大鼠、兔和狗静脉注射剂量为10mg/kg。在大鼠和狗中研究了多次口服40mg/kg非放射性标记的芬布芬。芬布芬及其代谢物的血浆浓度呈剂量依赖性,在所研究的剂量范围(10-100mg/kg)内,曲线下面积在种内和种间均呈一般线性关系。给大鼠和豚鼠口服10mg/kg的14C-芬布芬后,在所有检测的组织中均有放射性。除胃肠道、肝脏和肾脏外,这些组织中的水平在给药后24小时内通常低于相应的血浆水平。大鼠、豚鼠和狗血浆中主要的药物相关物质是(1,1'-联苯)-乙酸;在猴中是γ-羟基(1,1'-联苯)-4-丁酸。这两种化合物以及未变化的芬布芬存在于所有研究动物的血浆中。此外,在大鼠血浆中发现了4'-羟基(1,1'-联苯)-4-乙酸,在狗血浆中发现了β,γ-二羟基(1,1'-联苯)-4-丁酸。在大鼠(长达10天)或狗(长达18个月)中,多次每日口服40mg/kg的芬布芬期间,芬布芬及其代谢物的血浆图谱没有变化。从给予芬布芬的小鼠、大鼠、豚鼠、狗和/或猴的尿液中,以不同比例分离并鉴定出总共11种代谢物(包括上述那些)以及芬布芬本身。在所研究的每个物种中,静脉注射剂量后尿液和粪便中药物相关物质的排泄模式与口服剂量后的相似。一般来说,尿液是主要的排泄途径。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验